tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mara Goldstein, 206 are a BUY (81.1%), 46 are a HOLD (18.11%), 2 are a SELL (0.79%).
Analyst Mara Goldstein, currently employed at MIZUHO, carries an average stock price target met ratio of 54.04% that have a potential upside of 59.78% achieved within 405 days. Previously, Mara Goldstein worked at CANTOR FITZGERALD.
Mara Goldstein’s has documented 483 price targets and ratings displayed on 43 stocks. The coverage is on Healthcare, Communication Services, Technology sectors.
Most recent stock forecast was given on IOVA, Iovance Biotherapeutics at 18-Aug-2026.
Analyst best performing recommendations are on CRVS (CORVUS PHARMACEUTICALS).
The best stock recommendation documented was for CRVS (CORVUS PHARMACEUTICALS) at 5/8/2023. The price target of $3.5 was fulfilled within 30 days with a profit of $2.2 (169.23%) receiving and performance score of 56.41.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Feb-2019
$101
$-7.24 (-6.69%)
$101
7 years 12 days ago
(01-Nov-2019)
3/9 (33.33%)
$-7.53 (-6.94%)
187
Hold Since 01-Nov-2019
$115
$6.76 (6.25%)
$102
7 years 12 days ago
(01-Nov-2019)
3/13 (23.08%)
$6.47 (5.96%)
382
Hold Since 01-Nov-2019
$102
7 years 12 days ago
(01-Nov-2019)
1/1 (100%)
$18.78 (22.57%)
322
Buy Since 07-Nov-2016
$100
$-8.24 (-7.61%)
$128
7 years 2 months 25 days ago
(19-Aug-2019)
4/7 (57.14%)
$4.78 (5.02%)
125
Buy Since 23-May-2018
7 years 5 months 24 days ago
(20-May-2019)
0/4 (0%)
$24.59 (18.16%)
Which stock is Mara Goldstein most bullish on?
What Year was the first public recommendation made by Mara Goldstein?
